Inari Medical (NASDAQ:NARI – Get Free Report) and STRATA Skin Sciences (NASDAQ:SSKN – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations and institutional ownership.
Valuation and Earnings
This table compares Inari Medical and STRATA Skin Sciences’ top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Inari Medical | $493.63 million | 6.34 | -$1.64 million | ($0.41) | -131.29 |
STRATA Skin Sciences | $33.36 million | 0.35 | -$10.83 million | ($3.30) | -1.01 |
Inari Medical has higher revenue and earnings than STRATA Skin Sciences. Inari Medical is trading at a lower price-to-earnings ratio than STRATA Skin Sciences, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
Profitability
This table compares Inari Medical and STRATA Skin Sciences’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Inari Medical | -4.54% | -1.65% | -1.23% |
STRATA Skin Sciences | -34.92% | -65.76% | -19.69% |
Analyst Ratings
This is a summary of recent recommendations and price targets for Inari Medical and STRATA Skin Sciences, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Inari Medical | 0 | 3 | 4 | 0 | 2.57 |
STRATA Skin Sciences | 0 | 0 | 0 | 0 | N/A |
Inari Medical presently has a consensus target price of $64.83, suggesting a potential upside of 20.44%. STRATA Skin Sciences has a consensus target price of $38.00, suggesting a potential upside of 1,037.72%. Given STRATA Skin Sciences’ higher possible upside, analysts clearly believe STRATA Skin Sciences is more favorable than Inari Medical.
Volatility & Risk
Inari Medical has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500. Comparatively, STRATA Skin Sciences has a beta of 1.41, suggesting that its stock price is 41% more volatile than the S&P 500.
Summary
Inari Medical beats STRATA Skin Sciences on 9 of the 13 factors compared between the two stocks.
About Inari Medical
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
About STRATA Skin Sciences
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
Receive News & Ratings for Inari Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inari Medical and related companies with MarketBeat.com's FREE daily email newsletter.